Fluzone Quadrivalent

BIOLOGICAL6 trials

Sponsors

VaxInnate Corporation, Codagenix, Inc, Novavax, University of Miami, Centers for Disease Control and Prevention

Conditions

Breast CancerBreast Cancer Triple NegativeImmune DefectInfluenzaInfluenza, Human

Phase 1

Safety Study of Live Attenuated Influenza Vaccine, CodaVax

CompletedNCT03926416

Codagenix, IncInfluenza

Start: 2017-02-21End: 2018-09-14Updated: 2020-07-23

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

WithdrawnNCT06229392

Rush University Medical CenterBreast Cancer, Breast Cancer Triple Negative

Start: 2026-06-01End: 2027-12-31Updated: 2026-03-11

Phase 2

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

VaxInnate CorporationInfluenza

Start: 2015-05-31End: 2016-06-30Target: 450Updated: 2015-06-26

Phase 3

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

CompletedNCT04120194

NovavaxInfluenza, Human

Start: 2019-10-14End: 2020-12-13Updated: 2023-05-06

Phase 4

Opioid, HIV and Immune System

Active, not recruitingNCT04304768

University of MiamiImmune Defect

Start: 2020-11-18End: 2027-12-31Target: 400Updated: 2026-03-27

Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

CompletedNCT05514002

Centers for Disease Control and PreventionInfluenza, Human

Start: 2022-09-13End: 2023-12-31Updated: 2026-07-30

Related Papers

Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18–64 Years: Results and Experience From a Randomized, Double-Blind Trial

Open Forum Infectious Diseases2024-09-268 citations

Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial.

2021-09-2349 citations